Gene (SNP rs no.) | Model | Genotype | Eczema % (n/total) | RR†| 95% CI |
---|---|---|---|---|---|
IL13 (rs20541) | Â | Â | Â | Â | Â |
IOW study‡ | Co-dominant | GG | 12.8 (357/2781) | 1.00 | – |
 |  | AG | 14.3 (194/1357) | 1.10 | 0.88 – 1.38 |
 |  | AA | 16.9 (24/142) | 1.37 | 0.83 – 2.25 |
 |  |  | p-trend * | 0.08 |  |
 | Dominant | GG | 12.8 (357/2781) | 1.00 | – |
 |  | AG/AA | 14.5 (218/1499) | 1.13 | 0.91 – 1.40 |
PAPA study | Co-dominant | GG | 9.5 (92/967) | 1.00 | – |
 |  | AG | 12.3 (49/397) | 1.27 | 0.92 – 1.76 |
 |  | AA | 11.6 (5/43) | 1.14 | 0.49 – 2.68 |
 |  |  | p-trend * | 0.147 |  |
 | Dominant | GG | 9.5 (92/967) | 1.00 | – |
 |  | AG/AA | 12.3 (54/440) | 1.26 | 0.91 – 1.73 |
STAT6 (rs1059513) | Â | Â | Â | Â | Â |
IOW study‡ | Co-dominant | TT | 13.6 (467/3438) | 1.00 | – |
 |  | TC | 12.8 (106/830) | 0.92 | 0.70– 1.20 |
 |  | CC | 28.6 (12/42) | 2.21 | 1.05 – 4.66$ |
 |  |  | p-trend * | 0.54 |  |
 | Dominant | TT | 13.6 (467/3438) | 1.00 | – |
 |  | TC/CC | 13.5 (118/872) | 0.98 | 0.75 – 1.27 |
PAPA study | Co-dominant | TT | 9.8 (106/1082) | 1.00 | – |
 |  | TC | 12.3 (38/308) | 1.33 | 0.94 – 1.88 |
 |  | CC | 10.5 (2/19) | 1.16 | 0.31 – 4.30 |
 |  |  | p-trend * | 0.243 |  |
 | Dominant | TT | 9.8 (106/1082) | 1.00 | – |
 |  | TC/CC | 12.2 (40/327) | 1.32 | 0.93 – 1.86 |